no consistent signal for organ toxicity or long-term harm across decades of use Special Populations: Clinical experience exists in elderly patients with dementia and stroke patients, populations where safety data is particularly valuable IV Administration Considerations: Requires clinical administration setting for intravenous dosing, which limits convenience but ensures medical oversight Dihexa: Unknown Human Safety Profile Dihexa has never been administered to humans in any controlled setting, creating a complete absence of human safety data: No Human Pharmacokinetics: Absorption, distribution, metabolism, and excretion parameters are unknown in humans Theoretical c-Met Oncogenesis Concern: The c-Met/HGF pathway is implicated in cancer progression aberrant c-Met signaling promotes tumor growth, metastasis, and angiogenesis in multiple cancer types
10.1111/echo.14299 6 BergaminiC.CicoiraM.RossiA.VassanelliC
Clinical trials show average weight loss of 15-22.5% of body weight over 72 weeks with tirzepatide alone
Graf K, Last A, Gratz R, Allert S, Linde S, Westermann M et al
In this conversation, she opens up about what nobody warns you about the brutal month and a half of Suboxone withdrawal, finding leftover drugs in her home days after the funeral, the moment anger (not strength) saved her from relapsing, and why she now believes recovery was training for grief